229 related articles for article (PubMed ID: 87201)
41. Selective inhibition of a high affinity type IV cyclic AMP phosphodiesterase in bovine trachealis by AH 21-132. Relevance to the spasmolytic and anti-spasmogenic actions of AH 21-132 in the intact tissue.
Giembycz MA; Barnes PJ
Biochem Pharmacol; 1991 Jul; 42(3):663-77. PubMed ID: 1650218
[TBL] [Abstract][Full Text] [Related]
42. Cyclic nucleotide phosphodiesterases and human arterial smooth muscle cell proliferation.
Rybalkin SD; Bornfeldt KE
Thromb Haemost; 1999 Aug; 82(2):424-34. PubMed ID: 10605733
[No Abstract] [Full Text] [Related]
43. Inhibition of cyclic AMP phosphodiesterase activity and myocardial contractility: effects of cilostamide, a novel PDE inhibitor, and methylsiobutylxanthine on rabbit and canine ventricular muscle.
Endoh M; Satoh K; Yamashita S
Eur J Pharmacol; 1980 Aug; 66(1):43-52. PubMed ID: 6157546
[No Abstract] [Full Text] [Related]
44. Selective inhibition of separated forms of cyclic nucleotide phosphodiesterase from rat heart by some cardio- or vaso-active butenolide derivatives.
Némoz G; Prigent AF; Picq M; Pacheco H
Biochem Pharmacol; 1982 Nov; 31(21):3353-8. PubMed ID: 6293510
[No Abstract] [Full Text] [Related]
45. Cyclic nucleotide phosphodiesterase isoenzymes in guinea-pig tracheal muscle and bronchorelaxation by alkylxanthines.
Miyamoto K; Kurita M; Sakai R; Sanae F; Wakusawa S; Takagi K
Biochem Pharmacol; 1994 Sep; 48(6):1219-23. PubMed ID: 7945415
[TBL] [Abstract][Full Text] [Related]
46. Relaxation of guinea-pig trachea by cyclic AMP phosphodiesterase inhibitors and their enhancement by sodium nitroprusside.
Turner NC; Lamb J; Worby A; Murray KJ
Br J Pharmacol; 1994 Apr; 111(4):1047-52. PubMed ID: 8032589
[TBL] [Abstract][Full Text] [Related]
47. Phosphodiesterase IV inhibitors synergistically potentiate relaxation induced by forskolin in guinea-pig trachea.
Tanizawa M; Watanabe T; Kume H; Yamaki K; Miyamoto K; Takagi K
Clin Exp Pharmacol Physiol; 1998 Feb; 25(2):114-9. PubMed ID: 9493499
[TBL] [Abstract][Full Text] [Related]
48. Analysis of the relaxant effects of AH 21-132 in guinea-pig isolated trachealis.
Small RC; Boyle JP; Duty S; Elliott KR; Foster RW; Watt AJ
Br J Pharmacol; 1989 Aug; 97(4):1165-73. PubMed ID: 2551442
[TBL] [Abstract][Full Text] [Related]
49. Potentiation of nonadrenergic neural relaxation in guinea pig airways by a cyclic cAMP phosphodiesterase inhibitor.
Rhoden KJ; Barnes PJ
J Pharmacol Exp Ther; 1990 Jan; 252(1):396-402. PubMed ID: 2153809
[TBL] [Abstract][Full Text] [Related]
50. Inhibition cyclic nucleotide phosphodiesterase by FPL 55712, an SRS-A antagonist.
Chasin M; Scott C
Biochem Pharmacol; 1978; 27(16):2065-7. PubMed ID: 214090
[No Abstract] [Full Text] [Related]
51. Flavonoids are selective cyclic GMP phosphodiesterase inhibitors.
Ruckstuhl M; Beretz A; Anton R; Landry Y
Biochem Pharmacol; 1979; 28(4):535-8. PubMed ID: 218594
[No Abstract] [Full Text] [Related]
52. Selective inhibition of rat lung cyclic AMP phosphodiesterase and cyclic GMP phosphodiesterase by cyclic nucleotides and their analogues and various drugs [proceedings].
Butt NM; Saeed SA; Collier HO
Biochem Soc Trans; 1980 Jun; 8(3):380-1. PubMed ID: 6249674
[No Abstract] [Full Text] [Related]
53. The influence of 8-Br 3', 5'-cyclic nucleotide analogs and of inhibitors of 3', 5'-cyclic nucleotide phosphodiesterase, on noradrenaline secretion and neuromuscular transmission in guinea-pig vas deferens.
Stjärne L; Bartfai T; Alberts P
Naunyn Schmiedebergs Arch Pharmacol; 1979 Aug; 308(2):99-105. PubMed ID: 228209
[TBL] [Abstract][Full Text] [Related]
54. Evidence that additional mechanisms to cyclic GMP mediate the decrease in intracellular calcium and relaxation of rabbit aortic smooth muscle to nitric oxide.
Weisbrod RM; Griswold MC; Yaghoubi M; Komalavilas P; Lincoln TM; Cohen RA
Br J Pharmacol; 1998 Dec; 125(8):1695-707. PubMed ID: 9886761
[TBL] [Abstract][Full Text] [Related]
55. Apparent irrelevance of cyclic nucleotides to the relaxation of tracheal smooth muscle induced by theophylline.
Kolbeck RC; Speir WA; Carrier GO; Bransome ED
Lung; 1979; 156(3):173-83. PubMed ID: 224270
[No Abstract] [Full Text] [Related]
56. Inhibition of lung cyclic AMP- and cyclic GMP-phosphodiesterases by flavonoids and other chromone-like compounds.
Ruckstuhl M; Landry Y
Biochem Pharmacol; 1981 Apr; 30(7):697-702. PubMed ID: 6264919
[No Abstract] [Full Text] [Related]
57. In vitro effects of PDE5 inhibitors sildenafil, vardenafil and tadalafil on isolated human ureteral smooth muscle: a basic research approach.
Gratzke C; Uckert S; Kedia G; Reich O; Schlenker B; Seitz M; Becker AJ; Stief CG
Urol Res; 2007 Feb; 35(1):49-54. PubMed ID: 17102958
[TBL] [Abstract][Full Text] [Related]
58. A structurally novel inhibitor of cGMP phosphodiesterase with vasodilator activity.
Booth RF; Lunt DO; Lad N; Buckham SP; Oswald S; Clough DP; Floyd CD; Dickens J
Biochem Pharmacol; 1990 Nov; 40(10):2315-21. PubMed ID: 2173927
[TBL] [Abstract][Full Text] [Related]
59. Resolution of soluble cyclic nucleotide phosphodiesterase isoenzymes, from liver and hepatocytes, identifies a novel IBMX-insensitive form.
Lavan BE; Lakey T; Houslay MD
Biochem Pharmacol; 1989 Nov; 38(22):4123-36. PubMed ID: 2480793
[TBL] [Abstract][Full Text] [Related]
60. Effects of polyphloretin phosphate (PPP) and quinterenol of cyclic nucleotide phosphodiesterase activities.
Curtis-Prior PB; Chan YH
Pharmacol Res Commun; 1981 Apr; 13(4):331-7. PubMed ID: 6270700
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
